Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like LM76 introduces “New Design” pillow blocks and flange blocks March 28, 2018 Metamorphic Manufacturing: The “Third Wave” of Digital Manufacturing? January 2, 2020 Axiomtek releases AIE500-901-FL Artificial Intelligence embedded system November 20, 2019